Related Experiment Video
Updated: May 28, 2026

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
Published on: April 28, 2022
Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant
A K Chapman1, S W Aucott, A M Milstone
1Division of Neonatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. achapman@mcvh-vcu.edu
Insights
Chlorhexidine gluconate (CHG) is a common antiseptic for skin cleansing. This review examines the safety of CHG use in preterm infants, addressing its frequent application in Neonatal Intensive Care Units despite limited data.
Area of Science:
- Neonatal medicine
- Infectious disease prevention
- Pediatric pharmacology
Background:
- Chlorhexidine gluconate (CHG) is a CDC-recommended topical antiseptic for skin cleansing prior to central venous catheter insertion in adults and children.
- Limited safety data restricts CHG recommendations for infants under 2 months old.
- CHG is frequently utilized in Neonatal Intensive Care Units (NICUs) across the United States.
Purpose of the Study:
- To review the existing safety data of chlorhexidine gluconate (CHG) use in preterm infants.
- To evaluate the clinical evidence supporting CHG application in neonatal populations.
Main Methods:
- Literature review of studies on CHG safety in preterm infants.
- Analysis of clinical trial data and observational studies.
- Synthesis of safety profiles and adverse event reporting.
Main Results:
- Inconclusive results regarding the safety of CHG in preterm infants.
- Potential for adverse events requires further investigation.
- Evidence suggests careful consideration for CHG use in this vulnerable population.
Conclusions:
- The safety of chlorhexidine gluconate (CHG) in preterm infants remains under investigation.
- Further research is necessary to establish definitive safety guidelines for CHG in neonatal intensive care settings.
- Clinical practice should weigh the benefits against the potential risks of CHG in preterm neonates.
Abstract:
Chlorhexidine gluconate (CHG) is a widely used topical antiseptic that is recommended by the Centers for Disease Control and Prevention for skin cleansing before central venous catheter insertion in adults and children. Because of limited safety data, CHG is not recommended for use in children <2 months of age. CHG is, however, frequently used in Neonatal Intensive Care Units across the United States. Here, we will review the safety of CHG use in preterm infants.
More Related Videos
Related Concept Videos
Hand hygiene
Hand washing...
Cleaning, Sterilization, and Disinfection
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Handwashing II: Pre-procedure and Initial Procedure Steps
The hand washing procedure itself includes the following steps. First, cover cuts, if any, on hands with a waterproof dressing. Cuts and abrasions can become contaminated with bacteria hindering the ability to clean the area thoroughly. In addition, repeated hand washing can worsen an injury. The nails must be short and clean, without nail paint...
Handwashing III: During the Procedure and Post-Procedure Steps

